These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 5217700)

  • 21. [Preventive treatment of postoperative thrombosis by a heparinoid].
    Pedinielli L; Masson L; Malavaud A; Rebouillat M
    Mars Med; 1968; 105(11):917-24. PubMed ID: 5746247
    [No Abstract]   [Full Text] [Related]  

  • 22. [On the management of retinal blood circulation disorders due to arteriosclerosis and their sequellae].
    Kager S
    Med Klin; 1967 Sep; 62(38):1466-7. PubMed ID: 5627988
    [No Abstract]   [Full Text] [Related]  

  • 23. [The therapeutic problem of arteriosclerotic arteriopathies of the lower extremities].
    Gatta L; Montemurro G
    Minerva Med; 1980 Apr; 71(16):1173-9. PubMed ID: 7375035
    [No Abstract]   [Full Text] [Related]  

  • 24. [Therapeutic fibrinolysis and arterial occlusive disease].
    Lasch HG; Schöndorf TH
    Verh Dtsch Ges Inn Med; 1981; 87():314-23. PubMed ID: 7331461
    [No Abstract]   [Full Text] [Related]  

  • 25. [Results of therapy with heparinoid extracts on arteriosclerosis in the inner ear].
    Sperati G
    Minerva Otorinolaringol; 1969; 19(5):281-4. PubMed ID: 4191379
    [No Abstract]   [Full Text] [Related]  

  • 26. Unfractionated heparin and other antithrombin mediated anticoagulants.
    Adler BK
    Clin Lab Sci; 2004; 17(2):113-7. PubMed ID: 15168893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of batroxobin on atherosclerosis].
    Huang J; Zhou D; Tian L; Wu H; Zhang J; Zhang S; Chen H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Jun; 20(2):197-201. PubMed ID: 12856578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Activity of glucuronyl-glucosamine-glycan sulfate in patients with dyslipemia. Medium-term study].
    Pedrazzi F; Bonazzi L; Peterlin F
    Clin Ter; 1975 May; 73(4):327-42. PubMed ID: 1240795
    [No Abstract]   [Full Text] [Related]  

  • 29. [New synthetic antithrombotic agent. In secondary prevention conclusive, too].
    MMW Fortschr Med; 2003 Mar; 145(13):57. PubMed ID: 15101541
    [No Abstract]   [Full Text] [Related]  

  • 30. Is angiotensin receptor blockade antithrombotic?
    Lim HS; Lip GY
    Arch Intern Med; 2003 Dec 8-22; 163(22):2790-1; author reply 2792-3. PubMed ID: 14662638
    [No Abstract]   [Full Text] [Related]  

  • 31. Cardiology patient pages. Prevention of deep vein thrombosis and pulmonary embolism.
    Goldhaber SZ; Fanikos J
    Circulation; 2004 Oct; 110(16):e445-7. PubMed ID: 15492324
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of various drugs on the dynamics of fibrinolysis in humans].
    Brunetti S; Tesi M
    Riv Crit Clin Med; 1967 Aug; 67(3):233-45. PubMed ID: 5633715
    [No Abstract]   [Full Text] [Related]  

  • 33. Platelet-suppressive therapy in cardiovascular disease.
    Mehta J; Roy L
    Cardiovasc Clin; 1984; 14(3):211-34. PubMed ID: 6722852
    [No Abstract]   [Full Text] [Related]  

  • 34. [Use of allikor for the normalization of fibrinolysis and hemostasis in patients with chronic cerebrovascular diseases].
    Andrianova IV; Ionova VG; Demina EG; Shabalina AA; Karabasova IaA; Liutova LI; Povorinskaia TE; Orekhov AN
    Klin Med (Mosk); 2001; 79(11):55-8. PubMed ID: 11811113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombolytic therapy with CA-7, a fibrinolytic enzyme from Aspergillus oryzae: a report of two representative cases.
    Roschlau WH
    Can Med Assoc J; 1968 Apr; 98(16):757-61. PubMed ID: 5646112
    [No Abstract]   [Full Text] [Related]  

  • 36. [Attempts to use thrombolytics in cerebral circulatory deficiency syndromes originating of obliterative origin].
    Bureau Du Colombier H
    Angeiologie; 1967; 19(1):45-7. PubMed ID: 5596361
    [No Abstract]   [Full Text] [Related]  

  • 37. [Medical treatment of acute arterial obliteration in the limbs].
    Serradimigni A; Bory M; Poggi L; Audier M
    Rev Atheroscler (Paris); 1968; 10(2):3-8. PubMed ID: 5759950
    [No Abstract]   [Full Text] [Related]  

  • 38. [The antiatherosclerotic effects of a polysaccharide from raw animal stock].
    Rasulov MM; Velikaia MV; Zabozlaev AG; Kuznetsov IG; Voronkov MG
    Biull Eksp Biol Med; 1993 Nov; 116(11):460-2. PubMed ID: 7508765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preoperative care of microcirculatory vessels in patients with lower limb arteriosclerosis obliterans].
    Kuznetsov MR; Koshkin VM; Karalkin AV; Boldin BV; Rodionov SV; Sergeeva NA; Petukhov EB; Golosnitskiĭ PIu
    Angiol Sosud Khir; 2005; 11(1):19-24. PubMed ID: 16034319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Different Antithrombotic Regimens to Prevent Postoperative Restenosis in Patients With Lower Extremity Arteriosclerosis.
    Gao Z; Qin Y; Yu T; Wang W; Zhu CY; Qiao T; Li XQ; Da L; Ran F
    Am J Ther; 2021 Feb; 28(4):e517-e520. PubMed ID: 33443871
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.